Table 1 Clinic-pathologic characteristics of study population - our cohort.

From: Genomic predictive model for recurrence and metastasis development in head and neck squamous cell carcinoma patients

Patients (n = 104)

 

n (%)

 

n (%)

Gender

Age at diagnosis (Years)

Male

88 (84,6)

<60

52 (50)

Female

16 (15,4)

≥60

52 (50)

Anatomic Subsite

Invasion peri(neural)

Tongue

44 (42,3)

Yes

47(45,2)

Floor of the mouth

28 (26,9)

No

40(38,5)

Retromolar Trigone

8 (7,7)

NA

17(16,3)

Jugal Mucosa

6 (5,8)

Differentiation

Palate

4 (3,8)

Well

76 (73,1)

Alveolar ridge

6 (5,8)

Moderate

22 (21,2)

Tonsil

2 (1,9)

Poor

1(1,0)

Larynx

2 (1,9)

NA

5 (4,8)

Hypopharynx

2 (1,9)

Margins

Epiglottis

1 (1,0)

R0

59(56,7)

Supraglottis

1 (1,0)

R1

28(26,9)

Tobacco

NA

17(16,3)

Yes

76 (73,1)

HPV

No

28 (26,9)

Positive

3(2,9)

Alcohol

Negative

101(97,1)

Yes

70 (67,3)

Treatment

No

31 (29,8)

surgery alone

33 (31,7)

NA

3 (2,9)

Surgery + RT

42 (40,4)

TNM stage

Surgery + RT + QT

13 (12,5)

I

18 (17,3)

Surgery + QT

1 (1,0)

II

27 (26,0)

RT + QT

12 (11,5)

III

20 (19,2)

RT alone

3 (2,9)

IV

39 (37,5)

Vital status

  

Relapses/Metastasis in follow-up

40 (38,5)

Dead - OSCC

33 (31,7)

Dead-non-OSCC

6 (5,8)

Alive

65 (62,5)